# A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation

> **NCT06756490** · PHASE1 · RECRUITING · sponsor: **Sichuan Huiyu Pharmaceutical Co., Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Moderate or Severe Submental Fullness

## Interventions

- **DRUG:** HY-2003 (10 mg/ml), BELKYRA and placebo
- **DRUG:** HY-2003 (5 mg/ml) and placebo
- **DRUG:** HY-2003 (5 mg/ml) and placebo

## Key facts

- **NCT ID:** NCT06756490
- **Lead sponsor:** Sichuan Huiyu Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-26
- **Primary completion:** 2026-12-06
- **Final completion:** 2027-05-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06756490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06756490, "A Phase I Study of HY-2003 in the Subjects With Excessive Submental Fat Accumulation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06756490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*